Company Filing History:
Years Active: 2019
Title: Cristina Ana Gómez De La Oliva: Innovator in Cancer Treatment
Introduction
Cristina Ana Gómez De La Oliva is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer research through her innovative work on protein kinase inhibitors. Her dedication to advancing medical science has led to the development of valuable compounds that hold promise for treating various diseases.
Latest Patents
Cristina holds a patent for "Condensed tricyclic compounds as protein kinase inhibitors." This patent describes compounds of formula I, which are useful in the treatment of diseases where inhibition of a protein or lipid kinase, such as CDK8 and/or Haspin kinase, is desired. These compounds are particularly relevant in the treatment of cancer and proliferative diseases. She has 1 patent to her name, showcasing her innovative contributions to the field.
Career Highlights
Cristina is affiliated with the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO), where she conducts her research. Her work focuses on developing therapeutic strategies that target specific kinases involved in cancer progression. Her research has the potential to lead to new treatment options for patients suffering from various forms of cancer.
Collaborations
Cristina collaborates with esteemed colleagues, including Joaquín Pastor Fernández and Sonia Martínez González. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Cristina Ana Gómez De La Oliva is a trailblazer in the field of cancer research, with her innovative patent paving the way for new therapeutic approaches. Her work exemplifies the importance of scientific innovation in the fight against cancer and other proliferative diseases.